Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
0.324
+0.004 (1.38%)
Nov 20, 2024, 4:00 PM EST - Market closed
Biomerica Employees
Biomerica had 64 employees as of May 31, 2024. The number of employees increased by 2 or 3.23% compared to the previous year.
Employees
64
Change (1Y)
2
Growth (1Y)
3.23%
Revenue / Employee
$86,078
Profits / Employee
-$96,281
Market Cap
5.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Mainz Biomed | 71 |
| Kindly MD | 65 |
| Sharps Technology | 57 |
| Applied DNA Sciences | 55 |
| Organovo Holdings | 20 |
| Aethlon Medical | 14 |
| Portage Biotech | 7 |
| Mangoceuticals | 3 |
BMRA News
- 13 days ago - Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements - GlobeNewsWire
- 21 days ago - Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain - GlobeNewsWire
- 5 weeks ago - Biomerica Reports First Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 2 months ago - The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - GlobeNewsWire
- 2 months ago - Biomerica Reports Fiscal 2024 Year End Results - GlobeNewsWire
- 5 months ago - Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers - GlobeNewsWire
- 6 months ago - Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 - GlobeNewsWire
- 7 months ago - Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement - GlobeNewsWire